Trial Profile
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males With a Comparator Arm
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2019
Price :
$35
*
At a glance
- Drugs Setipiprant (Primary) ; Finasteride
- Indications Alopecia
- Focus Proof of concept; Therapeutic Use
- Sponsors Allergan
- 23 May 2018 Status changed from active, no longer recruiting to completed.
- 04 Apr 2018 Planned End Date changed from 5 Jun 2018 to 9 May 2018.
- 16 Oct 2017 Planned End Date changed from 30 Aug 2018 to 5 Jun 2018.